Diagnostic role of plasma ORM2 in differentiating prostate cancer from benign prostatic hyperplasia.
Ge Y, Xu B, Cai H, Jing W, Ouyang Q, Yuan Q, Li X, Fan Y, Shen Y, Shi Q, Wang Q, Cui L, Yin X, Ma G.
Ge Y, et al. Among authors: xu b.
J Cancer Res Clin Oncol. 2023 Jun;149(6):2301-2310. doi: 10.1007/s00432-022-04380-9. Epub 2022 Oct 5.
J Cancer Res Clin Oncol. 2023.
PMID: 36198834